期刊文献+

激活过氧化物酶增殖物激活受体对血管紧张素Ⅱ诱导内皮细胞中单核细胞趋化因子-1表达的影响 被引量:2

Effects of PPARs agonists on the MCP-1 expression induced by Ang Ⅱ in endothelial cells
原文传递
导出
摘要 目的探讨血管紧张素Ⅱ(AngⅡ)对人脐静脉内皮细胞分泌单核细胞趋化因子-1 (MCP-1)的影响,以及激活过氧化物酶增殖物激活受体(PPARs)中α、γ亚型对MCP-1的影响。方法以RT-PCR和ELISA方法测定AngⅡ在不同浓度(10-8-10-6 mol/L)对人脐静脉内皮分泌MCP-1的影响以及血管紧张素Ⅱ1型受体(AT1R)拮抗剂缬沙坦的干预作用;同时分析PPARα配体非诺贝特及PPARγ配体罗格列酮的干预对AngⅡ诱导MCP-1表达的效应。结果AngⅡ显著刺激人脐静脉内皮细胞系(HUVEC-12)表达MCP-1,增加的程度与AngⅡ的浓度呈正相关,罗格列酮和非诺贝特均可呈浓度依赖的抑制HUVEC-12中由AngⅡ所诱导的MCP-1的表达。结论AngⅡ可刺激HUVEC-12细胞表达MCP-1,其作用与AT1R受体相关;激动剂PPARα、PPARγ均可明显抑制AngⅡ所诱导的内皮细胞中MCP-1表达。 Objective To study the effect of angiotensin Ⅱ on the expression of monocyte chemoattractant protein-l(MCP-1) in cultured human umbilical vein endothelial cells(hUVEC), and the effect of peroxisome proliferator- activated receptors (PPARs) α and γ on MCP-1. Methods MCP-1 protein level was detected by enzyme-linked immunosorbent assay (ELISA) method, and the mRNA expression level of MCP-1 was determined by RT-PCR. Results Angiotensin Ⅱ distinctly increased the expression of MCP-1 in a dose-dependent manner in cultured hUVECs, and valsartan inhibited the expression of MCP-1 remarkably. Both rosiglitazone (PPARy agonist) and fenofibrate (PPARa agonist) concentrationdependently reduced the expression of MCP-1 in induced by Ang Ⅱ 10^-6 mol/L. Conclusions Angiotensin Ⅱ can increase the expression of MCP-1 evidently in hUVECs, which is inhibited by valsartan. The activation of PPARα and PPARγ can decrease the expression of MCP-1 in hUVECs.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2006年第9期664-667,共4页 Chinese Journal of Geriatrics
关键词 脐静脉 血管紧张素Ⅱ 单核细胞化学吸引蛋白质1 Umbilical vein Angiotensin Ⅱ Monocyte chemoattractant protein-1
  • 相关文献

参考文献12

  • 1Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine, 1999, 340: 115-126.
  • 2Nelken NA, Coughlin SR, Gordon D, et al. Monocyte chemoattractant proteln-1 in human atheromatous plaques. J Clin Invest, 1991, 88: 1121-1127.
  • 3Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res,2005,51 : 85-94.
  • 4Weiss D, Sorescu D, Taylor WR. Angiotensin Ⅱ and atherosclerosis. AmJ Cardiol, 2001, 87(suppl): 25C-32C.
  • 5Schiffrin EI., Amiri F, Benkirane K, et al. Peroxisome proliferator-activated receptors vascular and cardiac effects in hypertension. Hypertension, 2003,42: 664-668.
  • 6Nishimura H, Tsuji H, Masuda H, et al. Angiotensin Ⅱ increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost, 1997, 77: 1189-1195.
  • 7Hansson GK. Immune mechanisms in atherosclerosis.Arterioscler Thromb Vasc Biol, 2001, 21: 1876-1890.
  • 8Kim WJ, Chereshnev I, Gazdoiu M, et al. MCP-1 deficiency is associated with reduced intimal hyperpla siaafter arterial injury. Biochem Biophys Res Commun,2003, 310: 936-942.
  • 9Schecter AD, Rollins BJ, Zhang YJ, et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem, 1997, 272: 28568-28573.
  • 10Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature, 1998,393: 790-793.

同被引文献29

  • 1黄俊,覃国辉,马业新.转化生长因子-β_1及其胞内信号通路SMADs在大鼠心肌肥厚中的作用[J].中国病理生理杂志,2004,20(9):1601-1604. 被引量:11
  • 2Allen TJ,Jandeleit-Dahm KA.Preventing atherosclerosis with angiotensin-converting enzyme inhibitors:emphasis on diabetic atherosclerosis[J].Curr Drug Targets Cardiovasc Haematol Disord,2005,5:503-512
  • 3Strawn WB,Gallagher PE,Tallant EA,et al.AngiotensinⅡ AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats[J].J Cardiovasc Pharmacol,1999,33:341-351
  • 4Omura T,Yoshiyama M,Kim S,et al.Involvement of apoptosis signal-regulating kinase-1 on angiotensin Ⅱ-induced monocyte chemoattractant protein-1 expression[J].Arteroscler Thromb Vasc Biol,2004,24 (2):270-275
  • 5Martinovic I,Abegunewardene N,Seul M,et al.Elevated monocyte chemo -attractant protein 1 serum levels in patients at risk for coronary artery disease[J].Circ J,2005,69:1484-1489
  • 6Dragomir E,Tircol M,Manduteanu I,et al.Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells[J].Vascul Pharmacol,2006,44:440-449
  • 7Takebayashi K,Matsumoto S,Aso Y,et al.Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese type 2 diabetic patients[J].Diabetes Complications,2006,20:98-104
  • 8Mine S,Okada Y,Tanikawa T,et al.Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus[J].Biochem Biophys Res Commun,2006,344:780-785
  • 9Gosling J,Slaymaker S,Gu L,et al.MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B[J].J Clin Invest,1999,103:773-778
  • 10Bush E,Maeda N,Kuziel WA,et al.C C chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin Ⅱ -induced hypertension[J].Hypertension,2000,36:360-363

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部